MedPath

A comparative safety and efficacy evaluation of different formulations on Healthy Subjects with Spondylitis Difficulties.

Not Applicable
Registration Number
CTRI/2021/12/038614
Lead Sponsor
Akay Natural Ingredients Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Subjects with known history of spondylitis difficulties

2.Subject willing to adhere with their routine diet, physical activity, and general lifestyle throughout the study

3.Must be willing and able to give informed consent and comply with the study procedures.

Exclusion Criteria

1.Subjects with any chronic, acute ailments or with any other diagnosed disorders and under medications.

2.Subjects having symptoms of viral infection, including COVID-19 infection

3.Subjects on ongoing treatment for spondylitis with steroids, TNF-alpha inhibitors, etc

4.Subjects on other therapies such as homeopathy / Ayurveda

5.Subjects allergic to herbal products or any component of the study product

6.Known HIV or Hepatitis B positive or any other immuno-compromised state

7.History of clinically significant comorbidity

8.Diagnosis of any other clinically significant medical condition which in opinion of investigator may jeopardize subjectâ??s safety and preclude trial participation

9.Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study

10.Any additional condition(s) that in the Investigators opinion would warrant exclusion from the study or prevent the subject from completing the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean change in Spondylitis Disease Activity Index scores and inflammatory markersTimepoint: Day 0, Day 14 , Day 28, Day 42
Secondary Outcome Measures
NameTimeMethod
Change in Anti oxidant and other laboratory parametersTimepoint: Day 0, Day 14 , Day 28, Day 42;overall safety of the investigational productsTimepoint: Day 0, Day 14 , Day 28, Day 42
© Copyright 2025. All Rights Reserved by MedPath